AVTX
Avalo Therapeutics Inc
13.60$
-0.1%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -40.22 | -13,149.33 | -4,752.97 | 1,922.49 | -259.08 | -963.99 | -1,589.08 | -1,958.83 | -682.39 | -110.47 | -4.55 | -3.84 | |
| 0.08 | 30.41 | 8.76 | 65.34 | 377.25 | 195.66 | 72.24 | 45.78 | 4.23 | 0.57 | 0.02 | 0.03 | |
| 2.82 | 510.72 | 552.78 | 177.71 | 201.35 | 127.58 | 266.00 | 225.80 | 192.69 | 12.52 | 0.54 | 1.02 | |
| – | – | – | 78.70 | 2,183.14 | -125.63 | 1,001.68 | 226.41 | – | – | – | – | |
| -0.99 | 1,200.34 | 28.40 | -71.67 | 723.30 | -102.10 | -173.92 | 78.44 | 121.68 | -33.27 | -0.44 | 0.29 | |
| 0.05 | 25.86 | 11.38 | 3.58 | 46.75 | 13.20 | 2.47 | 3.12 | 2.42 | 0.57 | 0.00 | 0.00 | |
| -0.05 | -25.86 | -11.38 | -2,904.18 | 71.68 | -22.32 | 436.36 | -3.12 | -2.42 | -0.48 | 0.03 | -6.10 | |
| – | 1.78 | – | – | – | 54.46 | – | 909.07 | 377.68 | – | – | – | |
| – | -1.78 | – | – | – | -1.71 | -3.68 | 10.11 | 1.86 | 0.24 | 0.01 | 0.00 | |
| – | – | – | -364.56 | -21.21 | -12.90 | 1,289.64 | 909.07 | -377.68 | -76.49 | 0.00 | – | |
| 61.83 | 25,362.24 | -465.08 | 573.87 | 861.68 | 632.75 | 1,755.48 | 2,949.96 | -374.96 | 90.17 | 16.31 | 1.09 | |
| 21.57 | 12,187.05 | -5,229.43 | -407.82 | 674.28 | -353.56 | 602.76 | 988.01 | -1,059.77 | -20.78 | 11.79 | -8.85 | |
| -40.27 | -13,175.19 | -4,764.35 | 1,918.91 | -305.82 | -977.20 | -1,591.55 | -1,961.95 | -684.81 | -111.04 | -4.55 | -3.84 |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.